T. Markatseli

发表

Biologic Therapies and Autoimmune Phenomena

E. Pelechas, P. Voulgari, A. Drosos, 2021, Mediterranean journal of rheumatology.

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence

P. Voulgari, A. Drosos, P. Geborek, 2018, The Journal of Rheumatology.

The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study

A. Drosos, A. Georgiadis, T. Markatseli, 2022, Heart and Vessels.

Cancer diagnosis in a cohort of patients with Sjogren's syndrome and rheumatoid arthritis: a single-center experience and review of the literature.

N. Pavlidis, G. Pentheroudakis, A. Drosos, 2014, Anticancer research.

Cardiovascular Magnetic Resonance Detects Inflammatory Cardiomyopathy in Symptomatic Patients with Inflammatory Joint Diseases and a Normal Routine Workup

G. Kolovou, S. Mavrogeni, P. Voulgari, 2022, Journal of clinical medicine.

Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin

P. Voulgari, A. Drosos, A. Venetsanopoulou, 2020, Mediterranean journal of rheumatology.

Adalimumab-induced myasthenia gravis: case-based review

E. Pelechas, P. Voulgari, A. Drosos, 2020, Rheumatology International.

Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab.

P. Voulgari, A. Drosos, E. Kaltsonoudis, 2009, Clinical and experimental rheumatology.

Granuloma annulare induced by anti-tumour necrosis factor therapy

P. Voulgari, A. Drosos, T. Markatseli, 2007, Annals of the rheumatic diseases.

The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study

A. Drosos, A. Georgiadis, T. Markatseli, 2022, Heart and Vessels.

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.

A. Drosos, D. Daoussis, S. Liossis, 2017, Seminars in arthritis and rheumatism.

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

A. Drosos, S. Taraviras, D. Daoussis, 2019, Rheumatology International.

Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.

P. Voulgari, A. Drosos, Y. Alamanos, 2011, Seminars in arthritis and rheumatism.

Pleural effusion in psoriatic arthritis patients: a case series and review of the literature

M. Argyropoulou, P. Voulgari, A. Drosos, 2021, Clinical Rheumatology.

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival.

P. Voulgari, A. Drosos, P. Geborek, 2014, Seminars in arthritis and rheumatism.

In transit recurrence of Merkel cell carcinoma associated with polyarthritis effectively treated with immunocryosurgery.

P. Voulgari, I. Bassukas, G. Gaitanis, 2014, Acta dermato-venereologica.

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.

P. Voulgari, A. Drosos, Y. Alamanos, 2012, Clinical and experimental rheumatology.

Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry

Christos G. Papadopoulos, P. Voulgari, A. Drosos, 2019, Rheumatology advances in practice.

A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review

P. Voulgari, A. Drosos, I. Saougou, 2010, Clinical Rheumatology.

Fertility in male patients with seronegative spondyloarthropathies treated with infliximab.

P. Voulgari, A. Drosos, I. Saougou, 2013, Joint, bone, spine : revue du rhumatisme.

Co-stimulation modulation improves Rheumatoid Arthritis despite reducing the proportion of CD4+CD25high T regulatory cells

A. Drosos, C. Papagoras, T. Markatseli, 2016 .

Prognostic factors for erosive rheumatoid arthritis.

A. Drosos, C. Papagoras, T. Markatseli, 2010, Clinical and experimental rheumatology.

SAT0222 B Cell Depletion Therapy in Systemic Sclerosis Associated Interstitial Lung Disease. A Multicenter, Open Label, Comparative Study with A Follow up of 94 Patient-Years

A. Drosos, D. Daoussis, S. Liossis, 2016 .

Role of Hepcidin in Anemia of Chronic Disease in Rheumatoid Arthritis

P. Voulgari, G. Kolios, E. Bairaktari, 2021, Journal of Laboratory Physicians.

Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study

P. Voulgari, A. Drosos, Y. Alamanos, 2011, The Journal of Rheumatology.

Persistence and Adherence during the First Six Months of Tocilizumab Treatment Among Rheumatoid Arthritis Patients in Routine Clinical Practice in Greece. Results from the Single Arm REMISSION II Study (NCT01649817)

A. Drosos, A. Theodoridou, T. Markatseli, 2019, Mediterranean journal of rheumatology.

Persistent clinical response of infliximab treatment, over a 4-year period in ankylosing spondylitis

Christos G. Papadopoulos, P. Voulgari, A. Drosos, 2007, Rheumatology International.

Tuberculous pyomyositis in a rheumatoid arthritis patient treated with anakinra.

P. Voulgari, A. Drosos, P. Kosta, 2015, Clinical and experimental rheumatology.

Cardiovascular risk profile in patients with spondyloarthritis.

P. Voulgari, A. Drosos, Y. Alamanos, 2014, Joint, bone, spine : revue du rhumatisme.

Certolizumab for rheumatoid arthritis.

P. Voulgari, A. Drosos, C. Papagoras, 2014, Clinical and experimental rheumatology.

Effect of Hydroxychloroquine on the Lipid Profile of Patients with Sjögren Syndrome

P. Voulgari, A. Drosos, T. Markatseli, 2014, The Journal of Rheumatology.

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

A. Drosos, S. Taraviras, D. Daoussis, 2019, Rheumatology International.

Reply to the comment "Effect of Infliximab on Male Fertility" by Younis et al.

P. Voulgari, A. Drosos, C. Papagoras, 2014, Joint, bone, spine : revue du rhumatisme.

Maintained clinical response of infliximab treatment in ankylosing spondylitis: a 6-year long-term study.

P. Voulgari, A. Drosos, I. Saougou, 2010, Joint, bone, spine : revue du rhumatisme.